Neovasc Inc. Issuance/Purchase of Shares

Issuance/Purchase of Shares of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Issuance/Purchase of Shares growth rates and interactive chart.


Highlights and Quick Summary

  • Issuance/Purchase of Shares for the quarter ending December 31, 2021 was $0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Issuance/Purchase of Shares decreased by -100.0%
  • Annual Issuance/Purchase of Shares for 2021 was $66.4 Million (a 46.35% increase from previous year)
  • Annual Issuance/Purchase of Shares for 2020 was $45.4 Million (a 118.11% increase from previous year)
  • Annual Issuance/Purchase of Shares for 2019 was $20.8 Million (a 50.56% increase from previous year)
  • Twelve month Issuance/Purchase of Shares ending December 31, 2021 was $66.4 Million (a -7.28% decrease compared to previous quarter)
  • Twelve month trailing Issuance/Purchase of Shares decreased by -35.54% year-over-year
Trailing Issuance/Purchase of Shares for the last four month:
31 Dec '21 30 Sep '21 30 Jun '21 31 Mar '21
$66.4 Million $71.6 Million $87.9 Million $103 Million
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Issuance/Purchase of Shares of Neovasc Inc.

Most recent Issuance/Purchase of Sharesof NVCN including historical data for past 10 years.

Interactive Chart of Issuance/Purchase of Shares of Neovasc Inc.

Neovasc Inc. Issuance/Purchase of Shares for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $0.0 $0.0 $0.0 $66.4 $66.4
2020 $5.22 $16.31 $15.08 $8.76 $45.37
2019 $0.0 $0.0 $11.48 $9.32 $20.8
2018 $0.73 $0.0 $13.07 $0.02 $13.82
2017 $0.02 $0.01 $0.21 $0.02 $0.25
2016 $7.05 $0.0 $0.03 $0.05 $7.13
2015 $3.45 $-3.28 $0.04 $70.74 $70.97
2014 $22.5 $-22.72 $0.33 $22.39 $22.29
2013 $0.04 $0.42 $2.34 $0.07 $2.87
2012 $0.03 $0.0 $0.01 $0.0 $0.04
2011 $4.83 $4.83

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.